Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Celgene Corporation to Announce Third Quarter 2013 Results on October 24, 2013

  Celgene Corporation to Announce Third Quarter 2013 Results on October 24,

Will Host an Investor Webcast Event from the American College of Rheumatology
                         Meeting on October 27, 2013

Business Wire

SUMMIT, N.J. -- October 1, 2013

Celgene Corporation (NASDAQ:CELG) will host a conference call and live audio
webcast on Thursday, October 24, 2013 at 9 a.m. ET to discuss third quarter
2013 financial and operational results. The webcast can be accessed from the
Investor Relations page of the Company’s Web site at

Celgene will also  host a webcast of an investor event at the American College
of Rheumatology (ACR) Meeting on Sunday, October 27 at 6:30 p.m. PT (9:30 p.m.
ET). Members of Celgene’s management team and clinical investigators will
discuss the data presentations at the ACR Meeting. The event will be webcast
live and will be available in the Investor Relations section of the Company’s
web site at

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit

Forward-Looking Statements

This press release contains forward-looking statements, which are generally
statements that are not historical facts. Forward-looking statements can be
identified by the words "expects," "anticipates," "believes," "intends,"
"estimates," "plans," "will," “outlook” and similar expressions.
Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We
undertake no obligation to update any forward-looking statement in light of
new information or future events, except as otherwise required by law.
Forward-looking statements involve inherent risks and uncertainties, most of
which are difficult to predict and are generally beyond our control. Actual
results or outcomes may differ materially from those implied by the
forward-looking statements as a result of the impact of a number of factors,
many of which are discussed in more detail in our Annual Report on Form 10-K
and our other reports filed with the Securities and Exchange Commission.


Celgene Corporation
Jacqualyn A. Fouse, PhD, 908-673-9956
Executive Vice President and Chief Financial Officer
Patrick E. Flanigan III, 908-673-9969
Vice President, Investor Relations
Sponsored Links
Sponsored Links